Anem Waheed, M.D., MPH

Dr. Waheed graduated Summa Cum Laude with a Bachelor of Science degree in Biology and Anthropology from East Carolina University. She pursued her Medical Doctorate (MD) at the University of North Carolina at Chapel Hill School of Medicine where she received the prestigious William deB. MacNider Whitehead Award for a medical student who possesses various intangible traits of good character, including personal integrity, a sincere and genuine interest in the lives of others, a willingness to help others at all times, and humility. After graduation from medical school, Dr. Waheed completed her internal medicine residency at the University of Virginia. She received a Masters in Public Health (MPH) in Health Policy and Management from Harvard University. Dr. Waheed completed her Hematology and Medical Oncology Fellowship at Tufts Medical Center in Boston. Prior to joining the faculty at Weill Cornell Medicine, Dr. Waheed was a faculty member at Harvard Medical School and Massachusetts General Hospital (MGH) where she demonstrated a commitment to her patients in hematology/oncology, excelled in education and teaching of medical students and trainees, and developed a research career in complement-mediated and immune-mediated hematological disorders. Dr. Waheed has multiple peer-reviewed publications in prestigious journals including the New England Journal of Medicine, Blood, American Journal of Hematology, Journal of Thrombosis and Thrombolysis, Neuro Oncology, Journal of Clinical Oncology: Clinical Cancer Informatics, and Transfusion. Due to her work in this field, Dr. Waheed has gained recognition as a rising subject matter expert, earning invitations to speak regionally and nationally.  Dr. Waheed has also dedicated her time as a member of the American Society of Hematology (ASH), contributing to the ASH/Food and Drug Administration (FDA) Collaboration and Advocacy Leadership Institute, serving as an abstract reviewer, moderating sessions at the annual meeting, and participating on the subcommittee for Systems Based Hematology. On behalf of ASH, she has also met with several members of Congress in Washington, DC to advocate for the needs of hematology patients.